When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Alzheimer's: Are newly approved drugs making a real-life ...

   www.aol.com/alzheimers-newly-approved-drugs...

   After a lull of nearly 2 decades, the Food and Drug Administration (FDA) has approved some novel drugs for the treatment of Alzheimer’s disease since 2021. Most of these drugs are antibody ...

3. The FDA approved a new Alzheimer's drug - AOL

   www.aol.com/lifestyle/microdosing-candies-linked...

   💊 The FDA approved a new Alzheimer's drug. ... they did not show a significant reduction in cancer risk for people taking the diabetes medication metformin, which helps lower blood sugar levels

4. The Surprising Medication That May Lower Your Risk of Alzheimer's

   www.aol.com/surprising-medication-may-lower-risk...

   This drug wasn't designed to improve brain health, but it might be an added bonus.

5. Metformin - Wikipedia

   en.wikipedia.org/wiki/Metformin

   Preliminary studies have examined whether metformin can reduce the risk of Alzheimer's disease and whether there is a correlation between type 2 diabetes and the risk of Alzheimer's disease. [248] [249] While metformin may reduce body weight in persons with fragile X syndrome, whether it improves neurological or psychiatric symptoms is uncertain.

6. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   The study found that, compared to seven other anti-diabetic drugs, semaglutide was particularly effective in lowering the risk of Alzheimer's, as well as other GLP-1 medications in people. The study required participants to have at least one pre-existing health condition to participate, with the possibility that the cognitive decline may have ...

7. Anti-amyloid drugs - Wikipedia

   en.wikipedia.org/wiki/Anti-amyloid_drugs

   Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...